Manufacturing and Production

Showing 15 posts of 5872 posts found.

eu_flag

UK Government commits to funding EU research projects after Brexit

August 15, 2016 Manufacturing and Production, Research and Development brexit, research

Chancellor Phillip Hammond has outlined a government commitment to guarantee EU funding for British research projects made before Britain leaves …
top_ten

Top ten stories in the pharmaceutical industry this week

August 15, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest stories, pharma, pharmafile, stories of the week, top 10

It’s Monday and we’re just getting back to it after a busy week in pharma. Unfortunately, it was mostly bad …
novartis_side_building

Novartis invests €100 million to expand French manufacturing plant

August 15, 2016 Manufacturing and Production, Sales and Marketing Novartis, manufacturing

Novartis has sealed the deal with construction firm Jacobs Engineering group to expand production operations at its France Center of …
shutterstock_92671375

Valeant under criminal investigation

August 11, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Philidor, Valeant, investigation

Valeant Pharmaceuticals International is currently under investigation by the US attorney’s office in Manhattan over suspicions that the firm intentionally …
chronos_therapeutics

Chronos Therapetics strengthens management with two new vice presidents

August 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Private biotech Chronos Therapeutics has announced two new additions to its management team; Dr Fraser Murray and Dr Timonthy Schulz-Utermoehl …
josh-smiley

New senior VP, finance at Eli Lilly

August 10, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly

Eli Lilly has announced that Joshua Smiley is set to become senior vice president, finance, and treasurer from October 1, …
china-pharmaceutical-industry

New Agilent expansion will ‘more than double’ nucleic acid API manufacture

August 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Agilent, expansion, manufacturing, oligonucleotide

Agilent Technologies is set to expand its pharmaceutical manufacturing operations with a 20-acre facility in Weld County, Colorado. The facility …
biogen_austria_238

Biogen names haemophilia spin-off Bioverativ

August 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Biogen, bioverativ

Biogen has announced that Bioverativ will be the name of the standalone spin-off of its haemophilia and other blood disorders …
imlygic_amgen

NICE recommends Amgen’s Imlygic for advanced skin cancer

August 9, 2016 Manufacturing and Production, Sales and Marketing Amgen, Imlygic, NICE, skin cancer

NICE has published its final draft guidance recommending Amgen’s Imlygic (talimogene laherparepvec) for the treatment of advanced melanoma in adults …
pharma_pill_manufacturing

Helsinn and MEI Pharma join forces to develop leukaemia drug Pracinostat

August 9, 2016 Manufacturing and Production, Research and Development Helsinn, MEI Pharma, Pracinostat, chronic myeloid leukaemia

Swiss pharmaceutical group Helsinn has entered an agreement with MEI Pharma over the licensing, development and commercialisation of Pracinostat (SB939) …
ema_inside

New therapy wins EMA orphan drug designation for ALS

August 9, 2016 Manufacturing and Production, Research and Development EMA, Ice Bucket Challenge, ab science, als, masitinib, oprhan drug designation

French pharma company AB Science has announced that the European Medicines Agency has granted orphan drug status to masitinib for …
astrazeneca_building_white

AstraZeneca’s selumetinib fails to meet primary endpoint in lung cancer trial again

August 9, 2016 Manufacturing and Production AstraZeneca, failure, non-small cell lung cancer, phase III, selumetinib, trial failure

AstraZeneca has announced that its MEK 1/2 inhibitor, selumetinib, failed to meet its primary endpoint of progression free survival in …
joseph_papa

Management shake-up at Valeant as Papa expands senior team

August 9, 2016 Manufacturing and Production, Sales and Marketing Valeant, joseph papa, management, shake up

Joseph Papa continues to remodel the plagued Valeant Pharmaceuticals, as a senior management shake-up has seen several new arrivals and …
merckincweb2

FDA approves MSD’s Keytruda for head and neck cancer treatment

August 8, 2016 Manufacturing and Production, Research and Development Cancer, FDA, MSD, keytruda

The US Food and Drug Administration (FDA) has approved MSD’s Keytruda (pembrolizumab) for treatment of recurrent or metastatic head and …
bms

SMC reverses decision on Opdivo in advanced skin cancer

August 8, 2016 Manufacturing and Production, Research and Development SMC, Scottish Medicines Consortium, melanoma, opdivo, skin cancer

The Scottish Medicines Consortium (SMC) has reversed an earlier decision for Bristol-Myers Squibb’s Opdivo (nivolumab) and has now approved recommended …
The Gateway to Local Adoption Series

Latest content